BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1002 related articles for article (PubMed ID: 28143713)

  • 1. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial microparticle-promoted inhibition of vascular remodeling is abrogated under hyperglycaemic conditions.
    Jansen F; Zietzer A; Stumpf T; Flender A; Schmitz T; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Nov; 112():91-94. PubMed ID: 28919327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.
    Jansen F; Yang X; Hoelscher M; Cattelan A; Schmitz T; Proebsting S; Wenzel D; Vosen S; Franklin BS; Fleischmann BK; Nickenig G; Werner N
    Circulation; 2013 Oct; 128(18):2026-38. PubMed ID: 24014835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
    Chen Q; Yang F; Guo M; Wen G; Zhang C; Luong le A; Zhu J; Xiao Q; Zhang L
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):75-86. PubMed ID: 26493107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
    Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism.
    Jansen F; Yang X; Baumann K; Przybilla D; Schmitz T; Flender A; Paul K; Alhusseiny A; Nickenig G; Werner N
    J Cell Mol Med; 2015 Sep; 19(9):2202-14. PubMed ID: 26081516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.
    Yang F; Chen Q; He S; Yang M; Maguire EM; An W; Afzal TA; Luong LA; Zhang L; Xiao Q
    Circulation; 2018 Apr; 137(17):1824-1841. PubMed ID: 29246895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.
    Afzal TA; Luong LA; Chen D; Zhang C; Yang F; Chen Q; An W; Wilkes E; Yashiro K; Cutillas PR; Zhang L; Xiao Q
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27927633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2.
    Wang H; Wei Z; Li H; Guan Y; Han Z; Wang H; Liu B
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32373927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.
    Liu X; Cheng Y; Yang J; Qin S; Chen X; Tang X; Zhou X; Krall TJ; Zhang C
    J Am Heart Assoc; 2013 Oct; 2(6):e000407. PubMed ID: 24166492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.
    Zhang L; Chen Q; An W; Yang F; Maguire EM; Chen D; Zhang C; Wen G; Yang M; Dai B; Luong LA; Zhu J; Xu Q; Xiao Q
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2182-2194. PubMed ID: 28912364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function.
    Hall IF; Climent M; Quintavalle M; Farina FM; Schorn T; Zani S; Carullo P; Kunderfranco P; Civilini E; Condorelli G; Elia L
    Circ Res; 2019 Feb; 124(4):498-510. PubMed ID: 30582454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
    Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
    Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair.
    Zahedi F; Nazari-Jahantigh M; Zhou Z; Subramanian P; Wei Y; Grommes J; Offermanns S; Steffens S; Weber C; Schober A
    Cell Mol Life Sci; 2017 Jan; 74(2):359-372. PubMed ID: 27622243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.
    Reddy MA; Das S; Zhuo C; Jin W; Wang M; Lanting L; Natarajan R
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):864-73. PubMed ID: 26941017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
    Feng S; Gao L; Zhang D; Tian X; Kong L; Shi H; Wu L; Huang Z; Du B; Liang C; Zhang Y; Yao R
    Int J Biol Sci; 2019; 15(12):2615-2626. PubMed ID: 31754334
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo.
    Iaconetti C; De Rosa S; Polimeni A; Sorrentino S; Gareri C; Carino A; Sabatino J; Colangelo M; Curcio A; Indolfi C
    Cardiovasc Res; 2015 Sep; 107(4):522-33. PubMed ID: 25994172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.